Hillstream BioPharma, Inc. (HILS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.8M |
| Enterprise Value | -11.23M |
| P/E Ratio | -0.16 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 2.79 |
| Price/Book Ratio | 0.11 |
| Enterprise/Revenue | -22.11 |
| Enterprise/EBITDA | 0.62 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -65.59 |
| Operating Margin | -35.95 |
AD
Management Effectiveness
| Return On Assets | -0.17 |
| Return On Equity | -0.3 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0.01 |
| Gross Profit | 0 |
| EBITDA | 24,832 |
| Net Income | -35.92M |
| Diluted EPS | -1.12 |
Balance Sheet
| Total Cash | 37.24M |
| Total Cash/Share | 0.17 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 15.7 |
| Book Value Per Share | 2.1 |
Price History
| 52-Week Change | -63.65 |
| 52-Week High | 2.65 |
| 52-Week Low | 0.17 |
| Moving Average 50 Days | 0.25 |
| Moving Average 200 Days | 0.58 |
Statistics
| Average Volume | 684,778 |
| Shares Outstanding | 17.6M |
| % Held by Institutions | 0.12 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
